Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells
暂无分享,去创建一个
A. Sette | F. Chisari | A. Bertoletti | M. Levrero | C. Ferrari | A. Penna | F. Fiaccadori | M. Carli
[1] F. Chisari,et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.
[2] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[3] J. Lis,et al. Protein traffic on the heat shock promoter: Parking, stalling, and trucking along , 1993, Cell.
[4] D. Wiley,et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.
[5] H. Ploegh,et al. MHC class II dimer of dimers , 1993, Nature.
[6] A. McMichael,et al. Natural selection at work on the surface of virus-infected cells. , 1993, Science.
[7] M. Bevan,et al. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells , 1993, The Journal of experimental medicine.
[8] A. Vitiello,et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. , 1993, Journal of immunology.
[9] P. Allen,et al. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells , 1993, Nature.
[10] M. Masucci,et al. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. , 1993, Science.
[11] H. Grey,et al. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Vitiello,et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein , 1993, Journal of virology.
[13] R. Germain,et al. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling , 1993, The Journal of experimental medicine.
[14] F. Chisari,et al. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis , 1993, The Journal of experimental medicine.
[15] H. Dintzis,et al. Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arrays , 1992, The Journal of experimental medicine.
[16] F. Chisari,et al. Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines , 1992, Journal of virology.
[17] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[18] H. Grey,et al. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor , 1992, Cell.
[19] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[20] F. Chisari,et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[21] F. Chisari,et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen , 1991, The Journal of experimental medicine.
[22] M. Houghton,et al. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease , 1991, Hepatology.
[23] H. Rammensee,et al. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast , 1991, The Journal of experimental medicine.
[24] M. Luscher,et al. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis , 1991, Nature.
[25] Wei-Shau Hu,et al. Retroviral recombination and reverse transcription. , 1990, Science.
[26] Rolf M. Zinkernagel,et al. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.
[27] B. Tennant,et al. Lymphoid cells in the spleens of woodchuck hepatitis virus-infected woodchucks are a site of active viral replication , 1987, Journal of virology.
[28] J. Summers,et al. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells , 1986, Cell.
[29] F. Galibert,et al. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli , 1979, Nature.